Company intelligence / Profile preview

M. Shimoda

Plettenberg Bay, Western Cape, South Africa

Ownership: Private
Development stage: Other

Overview

Shimoda Biotech is a South African biotechnology company focused on the development of improved pharmaceutical products using proprietary drug delivery technologies. The company specializes in the use of cyclodextrins to enhance the solubility, stability, and bioavailability of established small molecule drugs. Their primary focus is on reformulating existing compounds to create value-added generics and new therapeutic options for pain management and oncology support. Shimoda's lead programs include injectable formulations designed for rapid onset and improved safety profiles in hospital settings.

Therapeutic areas: NeurologyGastroenterology
Modalities: Small moleculeDrug delivery system
Industry: Biotech

Partnerships

Javelin PharmaceuticalsHospiraPfizer

Beyond the preview

Go deeper on M. Shimoda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M. Shimoda.

Explore the full profile